A recent study by the US FDA indicates that even low doses of cannabidiol (CBD) may negatively impact liver function. The study involved 201 healthy participants, with 5.6% experiencing elevated liver enzymes after using CBD. While symptoms were absent and levels normalized after cessation, researchers caution about potential undetected liver damage and stress the need for further research on long-term effects and safety. Teljes cikk (Euronews.com)